Serum Trace Elements in Children with Well-Controlled and Drug Refractory Epilepsy Compared to Controls: An

Biswaroop Chakrabarty1, Ankush Singh Dogra1, G S Toteja2

  • 1Child Neurology Division, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.

Neurology India
|November 10, 2022
PubMed

Insights

Serum trace element levels, including selenium and copper, are altered in children with epilepsy, particularly in drug-refractory cases. Monitoring these micronutrients may benefit epilepsy management.

Area of Science:

  • Pediatric Neurology
  • Clinical Chemistry
  • Nutritional Science

Background:

  • Trace elements are increasingly recognized for their role in epilepsy pathogenesis.
  • Previous studies indicate altered serum trace element levels in children with epilepsy.

Purpose of the Study:

  • To quantify serum trace element levels in children with well-controlled and drug-refractory epilepsy.
  • To compare these levels against age and gender-matched controls.

Main Methods:

  • Serum selenium, copper, zinc, and iron were analyzed in 106 children with epilepsy (55 drug-refractory, 51 well-controlled) and 52 controls.
  • Participants were children aged 2-12 years from a North Indian tertiary care hospital.

Main Results:

  • Serum selenium and copper were significantly lower in children with epilepsy compared to controls.
  • This reduction was more pronounced in the drug-refractory epilepsy group.
  • Drug-refractory epilepsy cases also showed significantly reduced serum iron levels.

Conclusions:

  • Serum trace element levels are significantly altered in children with epilepsy, with notable differences in the drug-refractory subgroup.
  • Monitoring trace elements in epileptic children is recommended.
  • Investigating the therapeutic potential of addressing micronutrient imbalances in drug-refractory epilepsy warrants further study.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
244
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
408
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
802
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
549
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
35
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
246